Breast Cancer Clinical Trial
Official title:
Examining and Comparing Patient Satisfaction and Long-term Cosmetic Results Achieved With Implant-based Breast Reconstruction Surgery With Submuscular Silicone Implant After Skin Sparing / Areola Sparing / Nipple Sparing Mastectomy and Contralateral Symmetrization (With Mastopexy and/or Silicone Implant and/or Ultrapro Mesh) With Unilateral Simple Mastectomies and With Bilateral Skin-sparing Mastectomies and Implant-based Immediate Breast Reconstructions. Response-adaptive Prospective Randomized, Comparative Clinical Trial
This is a response-adaptive (RAR) prospective randomized study with a long-term follow-up and
the aim of this clinical study is to measure with qualitative and quantitative indicators the
changes in cosmetic results, quality of life and patient satisfaction after breast
reconstructive surgery with silicone implant (following SSM, ASM or NSM mastectomy) and
symmetrization (mastopexy and/or silicone implant and/or Ultrapro mesh sling technique) over
time.
According to the hypothesis of the study, the results of implant-based breast reconstruction
and symmetrization following advanced postmastectomy techniques significantly decrease over
time and later results limited patient satisfaction rate.
This is mainly due to the fact that over time, the natural breast differs from the
reconstructed breast with silicone implant. Because of the different biological properties
(gravity results ptosis on breast with mastopexy, significant volume increasement of the
breast with mastopexy due to endocrine therapy, gradually progressive capsular contracture on
the tumorous side, nipple flattening, nipple tattoo fading etc.) the two sides change
differently resulting in significant asymmetry and consequently could lead to decreased
patient satisfaction.
The high degree of asymmetry over time (which can be similar to the difference between the
result of a simple mastectomy and natural breast (control group)), may indicates additional
surgeries or usage of medical devices, putting a financial burden on the patient and the
health system. On the other hand, the symmetry can be achieved with bilateral skin-sparing
mastectomies and implant-based immediate or delayed-immediate reconstructions is clearly
better and change less with time. The mastectomy of the contralateral disease-free side is
considered as an unreasonable burden for moderate risk patients.
The information such as the need for multiple surgeries, change in symmetry over time etc.,
should be an important part of the professional decision-making mechanism and the surgeon
should inform the patient during the primer surgery. Nowadays due to the lack of
evidence-based knowledge, it is not part of the patient's information and surgical planning
internationally. Planning breast units, attention, capacity and financial resources must also
be provided to meet the long-term needs of patients who underwent postmastectomy breast
reconstruction. Simple mastectomy with an external prosthesis can be an alternative for
patients with intolerable degree of asymmetry or on the contrary, the results may justify the
need for bilateral mastectomy and reconstruction even in the absence of high oncological risk
and for purely symmetrical and cosmetic reasons.
Introduction The indication of total breast removal is primarily the part of a correct
oncological therapy, but secondly the removal of the full parenchyma can be prophylactic
among high risk patients with positive genetic testing. Unlike in the US, in Europe it is not
yet common to perform prophylactic breast surgery on the contralateral side among average
risk patients with unilateral breast cancer.
In modern breast surgery, mastectomy means the removal of the entire glandular tissue.
Surgery can be done in the absence of contraindication (eg, skin infiltration, mastitis
carcinomatosis), by preserving the nipple-areola complex (NAC) and the skin layer above the
parenchyma (nipple-sparing mastectomy, NSM) by removal of the whole or a part of the NAC
(skin-sparing mastectomy, SSM) or by removal of the nipple but with the preservation of the
areola (areola-sparing mastectomy, ASM).
It is important to emphasize that similarly to the classic simplex mastectomy in the cases of
SSM, ASM and NSM techniques provided by an experienced and qualified breast surgeon, the
complete oncological removal of the mammary gland is done.
The essence of advanced mastectomy techniques is that they ensure the combination of radical
oncological resection and immediate (immediate breast reconstruction, IBR) or
delayed-immediate breast reconstructive surgery (delayed immediate breast reconstruction,
D-IBR) (insertion of a tissue expander during the first operation, then as a second step
replace it with a silicone implant). It avoids all the burden and negative effects of distant
flap surgery, like donor scars, loss of movements etc.
One or two-step post-mastectomy breast reconstructive surgeries are mainly implant-based
techniques and less commonly autologous tissue techniques like distant pedicle flaps or free
flaps. The tissue expander or silicone implant is placed primarily in a submuscular position
but also can be inserted in a subcutaneous position in front of the large pectoral muscle.
The coverage of the lower pole or even the entire surface of the implant may be strengthened
with biological (so-called acellular dermal matrix) or synthetic materials (Ultrapro mesh) to
reduce the pressure load of the implant on the preserved skin, the consequent skin
perforation and so the loss of the implant.
The international literature of immediate or delayed-immediate postmastectomy breast
reconstructive techniques is extensive and the correlation between these procedures and the
oncological treatments (such as adjuvant radiotherapy) are well known. According to the
currently available evidence, reconstructive techniques do not adversely affect oncological
outcome, so these breast surgical techniques are nowadays considered standard procedures in
advanced breast cancer surgery.
The immediate or delayed-immediate implant-based reconstruction of the affected breast
following skin-sparing mastectomy techniques requires almost in all cases symmetrization of
the contralateral breast. Symmetrization surgery involves mastopexy, volume reduction or
silicone implant augmentation, or furthermore skin-sparing mastectomy with an implant-based
reconstruction corresponding to the tumorous side. Symmetrization can be performed in one
step with the tumorous breast surgery or more often at a deferred time.
Postmastectomy breast reconstruction surgeries are well-known as an effective rehabilitation
procedures, with significant psycho-oncological benefits to patients with low complication
rates and high patient satisfaction. Postmastectomy breast reconstructive surgery however
require more sophisticated surgical techniques, special expertise, longer surgical time and
significantly higher costs than simplex mastectomies.
The cosmetic results and patient satisfaction achieved with the immediate postmastectomy
reconstructive techniques with the use of symmetrisation, are widely studied, and high,
mainly in the early postoperative period.
However, the long-term results of the more and more popular and widespread usage of
skin-sparing mastectomies, immediate reconstructions and symmetrization surgery and the
related patient satisfaction rates have so far not or only barely been in the focus of
clinical trials, so the available scientific data is severely limited. The long-term
disease-free survival with multidisciplinary treatments in early stage breast cancer could
raise up to 85% of patients, so knowing the long-term changes of patient satisfaction,
cosmetic result and symmetry of stressful and expensive immediate or delayed-immediate
postmastectomy breast reconstruction surgeries is top priority.
Aim of the study
This is a response-adaptive (RAR) prospective randomized study with a long-term follow-up and
the aim of this clinical study is to measure with qualitative and quantitative indicators the
changes in cosmetic results, quality of life and patient satisfaction after breast
reconstructive surgery with silicone implant (following SSM, ASM or NSM mastectomy) and
symmetrization (mastopexy and/or silicone implant and/or Ultrapro mesh sling technique) over
time.
According to the hypothesis of the study, the results of implant-based breast reconstruction
and symmetrization following advanced postmastectomy techniques significantly decrease over
time and later results limited patient satisfaction rate.
This is mainly due to the fact that over time, the natural breast differs from the
reconstructed breast with silicone implant. Because of the different biological properties
(gravity results ptosis on breast with mastopexy, significant volume increasement of the
breast with mastopexy due to endocrine therapy, gradually progressive capsular contracture on
the tumorous side, nipple flattening, nipple tattoo fading etc.) the two sides change
differently resulting in significant asymmetry and consequently could lead to decreased
patient satisfaction.
The high degree of asymmetry over time (which can be similar to the difference between the
result of a simple mastectomy and natural breast (control group)), may indicates additional
surgeries or usage of medical devices, putting a financial burden on the patient and the
health system. On the other hand, the symmetry can be achieve with bilateral skin-sparing
mastectomies and implant-based immediate or delayed-immediate reconstructions is clearly
better and change less with time. The mastectomy of the contralateral disease-free side is
considered as an unreasonable burden for moderate risk patients.
The information such as the need for multiple surgeries, change in symmetry over time etc.,
should be an important part of the professional decision-making mechanism and the surgeon
should inform the patient during the primer surgery. Nowadays due to the lack of
evidence-based knowledge, it is not part of the patient's information and surgical planning
internationally. Planning breast units, attention, capacity and financial resources must also
be provided to meet the long-term needs of patients who underwent postmastectomy breast
reconstruction. Simple mastectomy with an external prosthesis can be an alternative for
patients with intolerable degree of asymmetry or on the contrary, the results may justify the
need for bilateral mastectomy and reconstruction even in the absence of high oncological risk
and for purely symmetrical and cosmetic reasons.
Patients and method Participation in the study is voluntary. In this response-adaptive (RAR)
prospective randomized study, the used standardized surgical techniques are considered to be
routine procedures in the literature and iat department as well. The oncological and
reconstructive surgeries do not represent new surgical procedures for patients either in
their technique nor in the indication, this prospective trial guarantee quantitative and
qualitative data collection only. Applied oncological therapies are unaffected by the study
and still follows the decisions of the Institute's preoperative and postoperative
multidisciplinary breast cancer committee. The study does not change the complex oncological
treatment in any way compared to the institute's protocol.
Response-adaptive classification in this study means that the choice of the optimal surgical
technique for the patient is not affected by the clinical trial. The selection of the
surgical technique is based on the decision-making models that is used for a long time, and
made individually for the patient's oncological disease (eg. nipple removal), breast size and
degree of ptosis (NSM vs. SSM), which is the same way as patients are treated out-of-study.
The principles of selecting symmetrizational techniques are presented in the introduction. In
addition, reinforcement with Ultrapro mesh is used during mastopexy when the degree of the
breast ptosis is at least Grade 3 or size D according to Regnault's classification or the
patient has significant pseudoptosis, so the fibrous system and the skin of the breast have a
very loose structure.
Therefore, in a scientific sense, this study does not involve treatments other than routine
treatment protocols.
Preoperative examinations:
- Physical examination
- Triplet examination of the breast
- Chest X-ray
- Axillary ultrasound with aspiration cytology if needed
- Required additional imaging based on the oncological staging (targeted x-ray, CT, MRI,
PET)
- Routine hematological and blood test analysis
- Measurements of jugulum-nipple width, nipple midline width, and nipple inframammary-fold
width
- Regnault Classification of breasts' ptosis
- Photo documentation (standard 5 directions and ap with raised arms) and the application
of the BCCT.core program (regarding data protection regulations)
- Filling out the BREAST-Q questionnaire
Recorded data:
Age, body mass, height, BMI, pre-/postoperative cup sizes, presence of preoperative breast
assymetry and its severity (BCCT.core software data), past history, medication, smoking
habits, oncological data, cTNM, pTN, pathological data, molecular genetic subtype,
neoadjuvant and adjuvant therapy, type of axillary treatment, locoregional cancer recurrance,
metastasis.
Age, weight, body mass, BMI, skin type typisation (normal, atypical, seborrheals, dehidrated,
hyperhydrated (oedamatic)), preoperative cup size, presence of preoperative breast assymetry
and its severity (BCCT.core software data), past history, medication, smoking habits,
oncological data, cTNM, pTN, pathological data, molecular genetic subtype, type of mastectomy
(SM, SSM,ASM, NSM), type of primary reconstruction, neoadjuvant and adjuvant therapy, type of
axillary treatment, type of delayed reconstruction, type and time of symmetrisation according
to primary surgery, type of the primer surgery, bra cup size after the reconstruction and
symmetrisation then measuring it yearly, the size of used silicone implant(s).
Postoperative complications were classified following Clavien-Dindo Classification.
Grade I complication (light inflammations, non-surgical haematoma or suffusion, seroma
formation, partial skin/NAC loss, limited fat necrosis, SSI and lymphoedema) does not require
medication or surgical treatment. Grade II complication is a Grade I complication that
requires medication or surgical interaction (antibiotic therapy, resuture due SSI and
multiple puncture due chronic seroma). Grade III complication requires invasive surgical
action (haematoma evacuation, chronic inflammation which requires reoperation, severe fat
necrosis, full skin/ NAC necrosis and wound dehiscense). Grade IV complication means
temporary organ failure. Grade V complication is one that leads to death.
The following data are collected in this trial: preoperative jugulum-nipple width,
nipple-midline width, nipple-IMF width, vertical and horizontal width of the areola, Regnault
Classification of the breast ptosis then repeating the above measurements during the
follow-up (every 6 months) with parallel photo documentation, using BCCT.core program and
data recording of the BREAST-Q questionnaire and 5 point Likert-scale.
Methods Enrolled patients who require unilateral SSM, ASM, NSM, or bilateral SSM, ASM, NSM
with immediate- or delayed-immediate implant based reconstruction, or only unilateral SM due
oncological reason, they filled out preoperative BREAST Q questionnaire and have undergone
preoperative photo documentation, BCCT.core software analysis. In case of neoadjuvant
therapy, the procedure is the same and the patient selection and data recording are performed
preoperatively.
The patients after oncological surgery receive adjuvant therapy based on the decision of the
multidisciplinary breast cancer board of the Institute. As a second step of the
reconstruction the expander-implant exchange and contralateral breast's symmetrization
happens at least 6 months after the adjuvant radiotherapy, and at least 3 months after the
adjuvant chemotherapy. This happens at the same time in case of bilateral skin sparing
mastectomies.
Data collection: measurements of the patients, the photo documentation, filling the BCCT.core
software database and the postoperative quality of life BREAST Q questionnaire made
postoperatively in the 4th-6th week. Nipple reconstruction performed until the postoperative
12-16th weeks in case of SSM and ASM. During the follow-up the above mentioned measurments,
photo documentation and quality of life questionnaire will be checked first in the 3rd
postoperative month then after every 6 months. The follow-up lasts until the end of the 5th
year. During this period, correction of the breast is not allowed. The BREAST-Q questionnaire
will be checked in every 6 months and the body measurements and photo documentation happens
yearly in the SM group until the end of the 5th postoperative year to evaluate the
contralateral breast's ptosis.
Surgical therapy The treatment of the patients examined in the study relied on the techniques
of the Breast and Sarcoma Department of the National Cancer Institute including standardized
SSM, ASM and NSM, and SM in the quality of life control group. (See the detailed description
of these: Z Mátrai, G Gulyás, T Kovács, M Kásler Principles and practice of oncoplastic
breast surgery. Medicina Kiadó Zrt, 2019. 8. fejezet: Tradicional breast surgery, 8.1.1.
Surgical technique of simple mastectomy and classical breast-consevring surgery; 11. fejezet
Postmastectomy breast reconstruction, 11.4. Immediate breast reconstruction, 11.6.
Skin-sparing and areola-sparing mastectomy, 11.7. Nipple-sparing mastectomy).
According to the valid protocol of the National Cancer Institute, the surgery of the axilla
can be either sentinel lymph node biopsy or axillary lymphadenectomy/ axillary block
dissection, if needed with radiotherapy of the axillary and supraclavicular region depending
on the regional stage of the breast cancer. (see as well in Z Mátrai, G Gulyás, T Kovács, M
Kásler Principles and practice of oncoplastic breast surgery. Medicina Kiadó Zrt, 2019. 8.
fejezet: Tradicional breast surgery, 8.1.2. Axillary lymph nodee dissection; 9. Sentinel
lymph node biopsy in breast cancer).
See the detailed standardized techniques of immediate or delayed-immediate breast
reconstruction below: Z Mátrai, G Gulyás, T Kovács, M Kásler Principles and practice of
oncoplastic breast surgery. Medicina Kiadó Zrt, 2019. 11. fejezet Postmastectomy breast
reconstruction, 11.4. Immediate breast reconstruction, 11.8. Subpectoral/subserratus implant
based breast reconstruction).
For the involved patients the principles of the symmetrization surgeries at Department is
standardized. To achieve the best result of symmetrisation, to built a natural shape breast
choosing an optimal implant size according to the footprint width, quality, quantity and the
tension of the skin at the ipsilateral tumorous breast side and volume increasement with
silicone implant augmentation in submuscular position and/or volume reduction and/or
mastopexy at the contralateral side.
According to the institutional practice the standardized inferior pedicle Wise technique for
mastopexy from an invert-T incision is chosen. If there is an expressed taint for ptosis, in
the subcutaneous layer an extra Ultrapro mesh sling is used (size of 7x15 cm) to suspened the
breast. (See detailed surgical technique: Z Mátrai, G Gulyás, T Kovács, M Kásler Principles
and practice of oncoplastic breast surgery. Medicina Kiadó Zrt, 2019. Chapter 12. Breast
shape and volume symmetrisation surgeries, nipple and areola reconstruction, 12.2. The link
between removal of the breast cancer and symmetrisation.) To compare the postoperative
aesthetic result of SSM and ASM, the nipple reconstruction and the NAC tattooing is
obligatory. The technique of the nipple reconstruction is standardized in enrolled patients.
(See detailed surgical technique: Z Mátrai, G Gulyás, T Kovács, M Kásler Principles and
practice of oncoplastic breast surgery. Medicina Kiadó Zrt, 2019. 12. fejezet Breast shape
and volume symmetrisation surgeries, nipple and areola reconstruction, 12.4.3. Techniques for
reconstructing the nipple.)
Using and collecting cosmetic results The following data collected in standing position
marking the midline and the IMF preoperatively then at the step of delayed reconstruction and
at symmetrization: jugulum-nipple width, nipple-midline width and nipple-IMF width.
The breast ptosis examination performed according to Regnault Classification at the beginning
and after symmetrization.
The primary aesthetic stage will be documented with standard photo documentation using valid
BCCT.core software making it measurable which allows us to compare it. the photo
documentation performed the standard way in 5 position (antero-posterior (ap), 45 degree
oblique and 90 degree lateral), in ap direction both ways arms up and down with strict
adherence to personal privacy policies. The patients are anonymous on the pictures without
their faces, and the photo documentation performed without jewelry. The mentioned software
counts measurements regarding to the photo documentation and gives a 4-point rating scale (1:
excellent, 2: good, 3: acceptable, 4: non-acceptable). These numerical results can be
statistically analyzed.
The quality of life is measured by BREAST-Q validated questionnaire. According to this, a
score is given in a 1-100 scale measuring the variables of "satisfaction with the breast",
"discomfort by radiotherapy", "psychosexual wellbeing" and "physical
wellbeing".Preoperatively a preoperative questionnaire and postoperatively a postoperative
questionnaire is filled. Higher rates show better quality of life. The questionnaires are
filled before the procedure and after the surgery in the 3rd months and every 6th months.
Likert scale is used (1. definitely not, 2: no, 3: abstain, 4: agree, 4: definitely agree)
for evaluating the subjective aesthetic outcome based on the photo documentation
(preoperative, 4 weeks after delayed reconstruction with symmetrization, 3rd months, every 6
months 5 years long). Based on the photo documentation three, non-involved breast surgeons
make the evaluation separately without communication. The results are collected and averaged.
Follow-up The follow-up is similar to the surgical and oncological follow-up in the National
Cancer Institute, so it is not a burden for the patients The primary check-up and data
registration performed preoperatively, the second check-up performed 4-6th weeks after the
delayed reconstruction and symmetrization then 3rd postoperative months with photo
documentation, body measurements, body mass calculation and BREAST-Q questionnaire.
After this the photo documentation, body measurements, body mass calculation and BREAST-Q
questionnaire examination performed every 6 months until the 5th year.
In SM group the body measurements, photo documentation made in the 3rd months and
measurements of the contralateral side and the BREAST-Q questionnaire performed every 12
months.
The bioethical background of the study It is a non-interventional clinical study is conducted
by the competent regional research ethics committees in accordance with the Medical law 164 /
A. § (2).
This non-interventional clinical trial is performed with the permission of the Ethical
Committee of the National Cancer Institute according to the 23/2002. (V.9.) Medical
Regulation.
The Researchers commit themselves to protect the patient's data, photo documentation in
accordance with the WHO Good Clinical Practice ( based on the Helsinki Declaration) and the
applicable provisions of the General Data Protection Regulation (GDPR) regarding the
international ethical and scientific quality requirements pertaining to the design, conduct,
documentation and reporting principles of tests conducted on humans.
Data collection and registration It is performed with the registration sheet for computer
processing and BREAST-Q questionnaire which is an internationally validated and authorized
mirror translated questionnaire. Digital photo documentation (standard 5 direction with
lowered arms and ap direction with raised arms) The BCCT.core made with at least 9 megapixel
photo documentation, ap and lateral directions with lowered and raised arm to calculate
numerically with a validated procedure the aesthetic outcome.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |